NCT06473337

Brief Summary

Role of vitamin D in cardiovascular disease is controversial. Here the investigators aimed to investigate the association of vitamin D deficiency and carotid plaque morphology as well as outcome of participants with high-grade carotid artery stenosis undergoing carotid endarterectomy. 332 consecutive participants undergoing carotid endarterectomy for symptomatic or asymptomatic carotid artery stenosis, were prospectively included in the study, and vitamin D levels were determined prior to surgery using chemiluminescence-immunoassay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
332

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 25, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

3 years

First QC Date

June 4, 2024

Last Update Submit

June 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vitamin D levels and its correlation with plaque vulnerability

    Vitamin D levels and its correlation with plaque vulnerability is the primary outcome measurement. Serum 25-hydroxy-vitamin D is measured by the Liaison Total 25-Hydroxy-Vitamin D chemiluminescence immunoassay (CLIA) on Liaison XL immunology analyzers (DiaSorin, Saluggia, Italy.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Vitamin D levels and its correlation with cardiac outcome

    through study completion, an average of 1 year

Interventions

Blood sampleDIAGNOSTIC_TEST

Serum blood sample for Vitamin D testing

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with carotid arteriosclerosis willing to perform surgery

You may qualify if:

  • Carotid arteriostenosis
  • Patient eligible for carotid artery surgery

You may not qualify if:

  • Oncologic disease
  • Patients with hemorrhagic, lacunar or cardioembolic stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General Surgery, Division of Vascular Surgery

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Vitamin D DeficiencyCarotid Artery Diseases

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Christoph Neumayer, MD,Prof.

    Medical University of Vienna, Department of General Surgery, Division of Vascular Surgery

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 25, 2024

Study Start

March 1, 2021

Primary Completion

March 1, 2024

Study Completion

March 1, 2024

Last Updated

June 25, 2024

Record last verified: 2024-06

Locations